
Metropolis Healthcare to Acquire Dehradun’s Leading Diagnostic Chain, Dr. Ahujas’ Pathology & Imaging Centre, Strengthening Its Position in North India
Metropolis Healthcare Limited, India’s second-largest and most respected pathology laboratory chain, has entered into a business transfer agreement to acquire Dehradun’s leading diagnostic chain - Dr. Ahujas’ Pathology and Imaging Centre (DAPIC). DAPIC, founded in 1990, has established itself as a trusted name in Uttarakhand’s diagnostic sector, known for its high standards of quality and accuracy. The organization operates two laboratories accredited by NABL and NABH, 11 patient service centres, and nine hospital-based centres. It offers a comprehensive range of pathology and soft radiology services, including ultrasound, ECG, and X-ray. In FY 2024-25, DAPIC recorded an estimated annual revenue of INR 11.5 crore (unaudited*), with pathology services contributing 73% and radiology services 27%. With 80 percent of its revenue coming from walk-in patients, the chain has built a strong B2C presence. Metropolis’ wholly owned subsidiary Metropolis Histoxpert Digital Services Private Limited, will acquire 100% ownership of DAPIC in an all-cash deal valued at INR 35.01 crores. The acquisition will further strengthen Metropolis’ ‘String of Pearls’ strategy aimed at building a robust and regionally diverse diagnostic network across North India.
Key Highlights
- Metropolis Healthcare to acquire Dehradun’s leading diagnostic chain, Dr. Ahujas’ Pathology & Imaging Centre.
- DAPIC has established itself as a trusted name in Uttarakhand’s diagnostic sector with high standards of quality and accuracy.
- DAPIC recorded an estimated annual revenue of INR 11.5 crore in FY 2024-25.
- 80 percent of DAPIC’s revenue comes from walk-in patients, indicating a strong B2C presence.
- Metropolis to acquire DAPIC in an all-cash deal valued at INR 35.01 crores.